![]() |
市場調查報告書
商品編碼
1959875
膀胱容量壓力測量導管市場-全球產業規模、佔有率、趨勢、機會和預測:按產品、應用、最終用戶、地區和競爭對手分類,2021-2031年Bladder Volume Manometer Catheter Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球膀胱容量測量導管市場預計將從 2025 年的 6.1648 億美元成長到 2031 年的 8.4089 億美元,複合年成長率為 5.31%。
這些專用醫療設備旨在透過膀胱測量腹內壓,從而能夠準確診斷高血壓等疾病。這些設備提供重症監護管理所需的關鍵數據,並取代了不可靠的臨床評估方法,已成為不可或缺的工具。市場成長的主要促進因素包括:加護病房收治病患數量的增加、預防高腹壓相關器官衰竭的迫切需求,以及創傷救治中對微創監測解決方案日益成長的需求。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 6.1648億美元 |
| 市場規模:2031年 | 840,890,000 美元 |
| 複合年成長率:2026-2031年 | 5.31% |
| 成長最快的細分市場 | 間歇性導尿管 |
| 最大的市場 | 北美洲 |
然而,由於各醫療機構對標準化監測通訊協定的應用並不一致,市場存在許多障礙。許多醫療機構由於缺乏對壓力管理標準的認知和訓練不足,尚未採用這些專用導管。世界腹膜內壓力症候群協會(WSACS)2024年的數據凸顯了這個問題,數據顯示,只有41%的醫護人員將既定的腹腔內壓力管理指引正式納入日常診療實務。這種對診斷通訊協定的低依從性顯著限制了市場的成長潛力。
推動先進膀胱容量壓力計導管加速普及的主要動力之一是臨床上日益重視降低導尿管相關尿道感染(CAUTI)的發生率。醫療機構擴大採用結合精確容量監測和壓力管理的導管系統,以降低過度擴張和後續感染的風險。朝向更嚴格的感染控制和以價值為導向的醫療模式轉變,正在實際改善病人安全。例如,美國疾病管制與預防中心(CDC)於2024年11月發布的《2023年國家和州醫療保健相關感染疾病進展報告》顯示,2022年至2023年美國急診醫院的CAUTI病例減少了11%,這凸顯了市場正向能夠提供關鍵數據並降低感染風險的先進設備轉變。
此外,膀胱功能障礙和尿失禁的日益普遍,使得慢性病照護和重症監護領域對可靠的監測解決方案的需求不斷成長。隨著全球膀胱相關疾病發生率的上升,對精準診斷工具的需求也日益迫切,以應對這些複雜的病例。 2024年9月,美國國家尿失禁協會(NAC)在新聞稿中指出,美國約有1億女性患有尿失禁,凸顯了龐大的患者族群亟需有效的治療。不斷擴大的患者群體直接推動了商業性成長。正如康維特集團2024年3月的報告所示,由於市場對其泌尿系統系統產品組合的強勁需求,該公司尿失禁護理業務實現了6.5%的有機收入成長。
標準化監測通訊協定實施不力是全球膀胱容量測量導管市場成長的主要障礙。儘管這些設備提供的腹腔內測壓法精度很高,但由於普遍缺乏認知和員工培訓不足,許多醫療機構無法將其納入常規重症監護流程。當醫護人員未能充分理解客觀壓力測量的必要性時,他們往往依賴主觀的臨床評估,而這些評估通常並不準確。這種對過時方法的依賴降低了人們對採購專用測壓導管的緊迫感,從而阻礙了市場滲透,並限制了其普及率。
近期統計數據凸顯了醫學領域教育差距的嚴重性。根據2024年世界腹腔腔室症候群協會會議的數據,僅有59%的醫護人員了解腹內高壓管理的最新指引。這一數字表明,先進的診斷技術與實際臨床實踐之間存在顯著差距。除非相當一部分目標使用者群體意識到腹壓監測不足的危害,否則對膀胱容量壓力計導管的需求將持續低迷,直接影響市場獲利能力。
業界正經歷著一場根本性的變革,即從間歇性的手動測量轉向自動化的即時數據收集,實現腹腔內壓力的連續監測。臨床醫生越來越傾向於選擇能夠提供動態分析的系統,以便早期發現腹腔內高壓(IAH),而不再使用只能瞬時記錄患者狀況的靜態模擬壓力表。現代設備透過將尿量和壓力測量整合到單一診斷流程中,簡化了工作流程,從而推動了這一轉變。 Accuryn Medical 在 2024 年 2 月發布的聲明證實,其 Accuryn 監測系統已用於治療約 7 萬名患者,這反映了臨床對即時生理數據的日益依賴,也印證了此類解決方案日益成長的需求。
另一個關鍵趨勢是開發多功能智慧導尿管,將溫度監測、壓力感測和容量測量整合於單一設備中。這項創新源於對高精度診斷工具的需求,這些工具能夠簡化複雜外科手術和急診護理環境中的病患管理。與傳統的Foley導管不同,這些先進的系統無需使用多種侵入性器械,即可對尿道狀況和膀胱功能全面評估。對這類整合泌尿系統技術的需求正在推動產業成長,科樂普公司2024年11月發布的報告也印證了這一點,該報告指出,該公司介入泌尿外科業務的有機收入在上一會計年度成長了5%。
The Global Bladder Volume Manometer Catheter Market is projected to expand from USD 616.48 Million in 2025 to USD 840.89 Million by 2031, reflecting a CAGR of 5.31%. These specialized medical instruments are designed to measure intra-abdominal pressure through the bladder, enabling the accurate diagnosis of conditions like intra-abdominal hypertension. By offering critical data for intensive care management and replacing unreliable clinical estimation techniques, these devices have become essential tools. The market is largely driven by the rising volume of intensive care admissions and the urgent need to prevent organ failure linked to high abdominal pressure, alongside a growing preference for minimally invasive monitoring solutions in trauma settings.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 616.48 MIllion |
| Market Size 2031 | USD 840.89 MIllion |
| CAGR 2026-2031 | 5.31% |
| Fastest Growing Segment | Intermittent Catheters |
| Largest Market | North America |
However, the market faces a substantial barrier due to the inconsistent application of standardized monitoring protocols across healthcare institutions. Many facilities have not adopted these specialized catheters, frequently due to a lack of awareness or insufficient training regarding pressure management standards. This issue is highlighted by 2024 data from the World Society of the Abdominal Compartment Syndrome, which indicated that only 41% of healthcare practitioners had formally integrated established guidelines for intra-abdominal pressure management into their daily practice. Such limited adherence to diagnostic protocols significantly restricts the market's potential for growth.
Market Driver
A primary factor accelerating the adoption of advanced bladder volume manometer catheters is the intensifying clinical focus on reducing Catheter-Associated Urinary Tract Infections (CAUTI). Healthcare institutions are increasingly favoring catheter systems that combine precise volume monitoring with pressure management to mitigate the risks of over-distension and subsequent infection. This transition toward strict infection control and value-based care has yielded tangible improvements in patient safety. For instance, the Centers for Disease Control and Prevention's '2023 National and State Healthcare-Associated Infections Progress Report', released in November 2024, noted an 11% decline in CAUTI cases within U.S. acute care hospitals between 2022 and 2023, underscoring the market shift toward sophisticated devices that reduce infection risks while providing vital data.
Additionally, the escalating prevalence of bladder dysfunction and urinary incontinence is boosting the demand for reliable monitoring solutions in both chronic and critical care environments. As the global incidence of bladder-related conditions grows, the need for accurate diagnostic tools to manage these complex cases becomes increasingly urgent. In September 2024, the National Association for Continence highlighted in a press release that nearly 100 million women in the U.S. suffer from urinary incontinence, emphasizing the massive population requiring effective management. This expanding patient base directly drives commercial growth, as evidenced by Convatec Group Plc's March 2024 report, which cited a 6.5% organic revenue increase in their Continence Care division due to strong demand for their urological portfolio.
Market Challenge
The inconsistent implementation of standardized monitoring protocols serves as a major impediment to the growth of the Global Bladder Volume Manometer Catheter Market. Despite the precision these devices offer in measuring intra-abdominal pressure, many medical facilities fail to integrate them into routine critical care due to a pervasive lack of awareness and inadequate staff training. When healthcare professionals do not fully appreciate the necessity of objective pressure measurement, they often revert to subjective clinical estimations, which are frequently inaccurate. This reliance on outdated methods diminishes the perceived urgency to procure specialized manometer catheters, thereby stalling market penetration and limiting adoption rates.
Recent statistics highlight the severity of this educational gap within the medical field. Data from the World Society of the Abdominal Compartment Syndrome in 2024 revealed that only 59% of healthcare practitioners were aware of current guidelines regarding the management of intra-abdominal hypertension. This figure underscores a significant disconnect between advanced diagnostic technology and actual clinical practice. As long as a substantial portion of the target user base remains uninformed about the dangers of unmonitored abdominal pressure, the demand for bladder volume manometer catheters will remain suppressed, directly hindering the market's revenue potential.
Market Trends
The industry is witnessing a fundamental shift toward continuous intra-abdominal pressure monitoring, replacing intermittent manual checks with automated, real-time data collection. Clinicians are increasingly moving away from static analog manometers, which offer only snapshots of a patient's status, in favor of systems that provide dynamic analytics for the early detection of intra-abdominal hypertension (IAH). This transition is supported by modern devices that streamline workflows by integrating urine output and pressure readings into a single diagnostic stream. The growing traction for such solutions is evident in Accuryn Medical's February 2024 announcement, which confirmed that their Accuryn Monitoring System has been used to treat nearly 70,000 patients, reflecting a rising clinical dependence on real-time physiological data.
Another dominant trend is the development of multi-parameter smart catheters, which converge temperature monitoring, pressure sensing, and volume measurement into a single device. This innovation is driven by the demand for high-fidelity diagnostic tools in interventional urology that simplify patient management in complex surgical and acute care settings. Unlike traditional Foley catheters, these advanced systems allow for comprehensive assessments of urethral integrity and bladder function without the need for multiple invasive instruments. This demand for integrated urological technologies is fueling sector growth, as reflected in Coloplast A/S's November 2024 report, which noted a 5% organic revenue increase in their Interventional Urology business for the fiscal year.
Report Scope
In this report, the Global Bladder Volume Manometer Catheter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Bladder Volume Manometer Catheter Market.
Global Bladder Volume Manometer Catheter Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: